Related Experiment Video
Updated: May 2, 2026

09:35
Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain
Published on: May 10, 2017
19.0K
Rechargeable occipital nerve stimulator systems: a patient satisfaction study
Sara Sciacca1, James Shand Smith, Harith Akram
1Victor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery , London , UK.
British Journal of Neurosurgery
|February 25, 2014
Summary
Patients with cluster headaches report high satisfaction with rechargeable batteries for occipital nerve stimulation (ONS). Most find recharging convenient and prefer it over non-rechargeable options for improved quality of life.
Area of Science:
- Neurology
- Neurosurgery
- Pain Management
Background:
- Cluster headache is a severe, disabling neurological condition affecting 0.12% of the population.
- Occipital nerve stimulation (ONS) with an implantable pulse generator (IPG) is a treatment for intractable cluster headaches.
- Rechargeable batteries offer a longer lifespan compared to non-rechargeable ones for ONS devices.
Purpose of the Study:
- To assess patient satisfaction with rechargeable batteries used in ONS for cluster headache treatment.
- To determine the convenience and perceived benefits of rechargeable ONS systems.
- To compare patient preference for rechargeable versus non-rechargeable batteries.
Main Methods:
- A survey was conducted with 100 patients who received ONS with rechargeable systems at a London hospital.
- Patient satisfaction was evaluated using a questionnaire adapted for rechargeable IPGs.
- Ninety-two patients participated, with some having prior experience with non-rechargeable batteries.
Main Results:
- 74% of patients found recharging the battery convenient.
- 88% felt the inconvenience of recharging was outweighed by the stimulation benefits.
- 84% of patients who previously used non-rechargeable batteries preferred the current rechargeable system.
Conclusions:
- ONS with a rechargeable battery system demonstrates positive patient outcomes.
- The high patient compliance and sample size provide a reliable estimation of effectiveness.
- Rechargeable IPGs for ONS may be the preferred system for patients undergoing this treatment.

